SB-649868

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for SB-649868, covering 2012-08-13 to 2017-08-08. Get the full timeline:

Most recent: Clinical Trial Update: 15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects. [Phase 1]

See pricing